Firdapse
| Chemical Name | amifampridine |
| Dosage Form | Tablet (oral; 10 mg) |
| Drug Class | Channel blockers |
| System | Nervous |
| Company | Catalyst Pharmaceuticals |
| Approval Year | 2018 |
Indication
- To treat Lambert-Eaton myasthenic syndrome in adults.
An independent source of information on U.S. brand name drugs for health professionals
An independent source of information on U.S. brand name drugs for health professionals
Current,
Evidence-Based
Information
Independent,
Comprehensive,
And Non-Biased
Designed For
Health
Professionals
In No Way
Influenced By
Third Parties